Related Experiment Videos
Interstitial photodynamic laser therapy in interventional oncology
Thomas J Vogl1, Katrin Eichler, Martin G Mack
1Department of Diagnostic and Interventional Radiology, University of Frankfurt, Theodor-Stern-Kai 7, 63590 Frankfurt/Main, Germany.
European Radiology
|March 27, 2004
Summary
Interstitial photodynamic therapy (PDT) offers a promising approach for treating solid tumors, particularly liver tumors. This locoregional cancer treatment utilizes light-activated photosensitizers to induce targeted tumor necrosis with minimal side effects.
Area of Science:
- Oncology
- Medical Physics
- Photochemistry
Background:
- Photodynamic therapy (PDT) is an established locoregional cancer treatment.
- PDT is primarily used for superficial or endoluminal lesions.
- Its application for solid tumors, including those in parenchymal organs, is expanding.
Purpose of the Study:
- To evaluate the efficacy and safety of interstitial PDT for solid tumors.
- To focus on the development of interstitial PDT for liver tumors.
- To assess PDT as a potential adjunct in locoregional cancer therapy.
Main Methods:
- Systemic administration of a photosensitizer.
- Interstitially delivered light activation of the photosensitizer in diseased tissue.
- Contrast-enhanced computed tomography (CECT) for monitoring treatment-induced changes.
Main Results:
- Interstitial PDT demonstrated effective induction of therapy-induced necrosis around the light-guiding device.
- Ablation of liver tumors appears feasible with the use of multiple interstitial devices.
- No severe side effects or toxicities were reported, indicating a favorable safety profile.
Conclusions:
- Interstitial PDT is a viable and developing treatment option for solid tumors, especially liver malignancies.
- PDT can be effectively applied to parenchymal organs using specialized delivery systems.
- PDT shows potential as a clinically relevant adjunct to existing locoregional therapy strategies in oncology.